Effectiveness Taif University P. O. Box 11099 Taif 21944 Effectiveness of Dry Needling in Management of Myofacial Trigger Point

November 6, 2022 updated by: Slwa Sami Alattar, Taif University

Effectiveness of Dry Needling in Management of Myofacial Trigger Point In Trapezius Muscle

myofascial pain syndrome is considered to be a chronic condition due to sensitive pressure points within the muscle recognized as trigger points

Generally the aim of this study will be :

  • To investigate the effectiveness of dry needling on trigger point in trapezius muscle
  • Evaluate the pain level before and after the applications of dry needling on trigger points
  • compare between the effects of dry needling and physical therapy exercise program

Study Overview

Status

Not yet recruiting

Study Type

Interventional

Enrollment (Anticipated)

40

Phase

  • Not Applicable

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

16 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Clinically active trigger point and expression of symptoms of neck pain in trapezius which had lasted for at least 3 months.
  • Having a pain level higher than 4 and lower than 8 on Visual Analogue Scale ( VAS )
  • Did not receive any other form of neck treatment during the previous month.

Exclusion Criteria:

  • Presence of cardiopulmonary disease , the application process requires the subject to be in prone position to expose the area of treatment, this position is un-preferable for cardiopulmonary patients
  • History of neck surgery
  • Trigger point treatment in the last 30 days
  • Any contraindications for dry needling such as local infection, skin disease ,severe postural disorder , tumor , rheumatoid arthritis, cervical spine stenosis and bilateral upper extremity symptoms
  • pregnancy

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Intervention group
The intervention group will receive sessions of dry needling to relief myofacial pain on trapezius
Active Comparator: Control group
Usual physical therapy protocol 4 sessions, two sessions per week each session will include a group of therapeutic exercises
Therapeutic exercise

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Pain level
Time Frame: 6 weeks
Will be determined using the visuals analogue scale (VAS)
6 weeks
Neck disability index
Time Frame: 6 weeks
questionnaire contains 10 items aiming to evaluate the limitation because of neck pain
6 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Depression
Time Frame: 6 weeks
Will be determined using the Beck's Depression Inventory ( BDI)
6 weeks
Neck Range of motion
Time Frame: 6 weeks
Will be measured using CROM
6 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Anticipated)

January 1, 2023

Primary Completion (Anticipated)

June 1, 2023

Study Completion (Anticipated)

June 1, 2023

Study Registration Dates

First Submitted

November 6, 2022

First Submitted That Met QC Criteria

November 6, 2022

First Posted (Actual)

November 14, 2022

Study Record Updates

Last Update Posted (Actual)

November 14, 2022

Last Update Submitted That Met QC Criteria

November 6, 2022

Last Verified

November 1, 2022

More Information

Terms related to this study

Other Study ID Numbers

  • 44-004

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Myofacial Trigger Points

Clinical Trials on Dry needling ,

3
Subscribe